Materials Characteristics
Apurun showcases detailed material characteristics references for our nanoparticle formulations. These references provide critical insights into the physical and chemical properties of our products, ensuring informed decision-making for your applications.
Reagent | Type | Molecular Weight | Transition Temperature | Charge Type | Used Applications | Important Criteria |
---|---|---|---|---|---|---|
DOTAP | Cationic Lipid | 698.09 g/mol | 23°C | Cationic | Gene Delivery | High transfection efficiency |
9A1P9 | Ionizable Lipid | 862.14 g/mol | 50°C | Ionizable | mRNA Delivery | Superior delivery performance |
DODMA | Ionizable Cationic Lipid | 620.99 g/mol | 20°C | Ionizable/Cationic | Gene Therapy | Versatility |
cKK-E12 | Ionizable Lipid | 881.13 g/mol | 60°C | Ionizable | Nucleic Acid Delivery | Efficacy |
Lipid-5 | Ionizable Lipid | 758.13 g/mol | 55°C | Ionizable | Lipid Nanoparticle Formulations | Stability |
Lipid 319 | Ionizable Lipid | 813.20 g/mol | 45°C | Ionizable | Therapeutic Delivery | High-efficiency |
DOTMA | Cationic Lipid | 693.32 g/mol | 22°C | Cationic | Gene Transfection | Reliability |
SM-102 | Ionizable Lipid | 710.13 g/mol | 25°C | Ionizable | Vaccines | Compatibility |
C12-200 | Ionizable Lipid | 854.12 g/mol | 52°C | Ionizable | Nucleic Acid Delivery | Efficiency |
ALC-0315 | Ionizable Lipid | 776.15 g/mol | 48°C | Ionizable | Lipid Nanoparticle Formulations | Stability |
DLin-MC3-DMA | Ionizable Lipid | 695.11 g/mol | 35°C | Ionizable | mRNA Therapeutics | Delivery Capabilities |
DLin-DMA | Ionizable Lipid | 670.10 g/mol | 30°C | Ionizable | Nucleic Acid Delivery | Versatility |
DSPE-PEG2000 | Phospholipid | 1000 g/mol | 45°C | Neutral | Stabilization | Biocompatibility |
DSPE-PEG5000 | Phospholipid | 1500 g/mol | 55°C | Neutral | Drug Delivery | Stability |
DPPG | Phospholipid | 500 g/mol | 40°C | Neutral | Lipid Nanoparticle Formulations | Membrane Interaction |
DMPG | Phospholipid | 450 g/mol | 35°C | Neutral | Drug Delivery | Biocompatibility |
DOPE | Phospholipid | 400 g/mol | 30°C | Neutral | Drug Delivery | Stability |
DPG | Phospholipid | 350 g/mol | 25°C | Neutral | Lipid Nanoparticle Formulations | Biocompatibility |
DPPC | Phospholipid | 600 g/mol | 50°C | Neutral | Drug Delivery | Stability |
DSPC | Phospholipid | 650 g/mol | 55°C | Neutral | Gene Delivery | Compatibility |
Reagent | Type | Molecular Weight | Transition Temperature | Charge Type | Applications | Important Criteria |
---|---|---|---|---|---|---|
PLGA | Biodegradable Polymer | 40,000 g/mol | 40°C | Neutral | Drug Delivery | Biocompatibility, Controlled release |
PCL | Biodegradable Polyester | 70,000 g/mol | 60°C | Neutral | Tissue Engineering | Biocompatibility, Mechanical strength |
PEG | Polyethylene Glycol | 5,000 g/mol | -60°C | Neutral | Lipid Formulations | Hydration, Solubility |
PVA | Polyvinyl Alcohol | 44.05 g/mol | 85°C | Neutral | Drug Delivery | Biocompatibility, Water solubility |
PVDF | Polyvinylidene Fluoride | 100.08 g/mol | 150°C | Neutral | Drug Delivery | Thermal stability, Chemical resistance |
PLA | Polylactic Acid | 88,000 g/mol | 55°C | Neutral | Biomedical Implants | Biocompatibility, Biodegradability |
Reagent | Type | Molecular Weight | Transition Temperature | Charge Type | Applications | Important Criteria |
---|---|---|---|---|---|---|
Cholesterol | Excipient | 386.65 g/mol | 40°C | Neutral | Lipid Formulations | Membrane rigidity, Stability |
PEG | Excipient | 44.05 g/mol | -60°C | Neutral | Lipid Formulations | Hydration, Solubility |
DSPC | Excipient | 734.08 g/mol | 55°C | Neutral | Drug Delivery | Stability, Biocompatibility |
DOPC | Excipient | 786.13 g/mol | 65°C | Neutral | Lipid Nanoparticle Formulations | Biocompatibility, Fluidity |
DMPC | Excipient | 678.10 g/mol | 45°C | Neutral | Nanoparticle Stability | Compatibility, Stability |
DLPC | Excipient | 546.09 g/mol | 40°C | Neutral | Drug Delivery | Bioavailability, Stability |
Reagent | Type | Molecular Weight | Transition Temperature | Charge Type | Applications | Important Criteria |
---|---|---|---|---|---|---|
DSPE-PEG2000 | Surfactant | 1000 g/mol | 45°C | Neutral | Stabilization | Biocompatibility |
DSPE-PEG5000 | Surfactant | 1500 g/mol | 55°C | Neutral | Drug Delivery | Stability |
DPPG | Surfactant | 500 g/mol | 40°C | Neutral | Lipid Nanoparticle Formulations | Membrane Interaction |
DMPG | Surfactant | 450 g/mol | 35°C | Neutral | Drug Delivery | Biocompatibility |
DOPE | Surfactant | 400 g/mol | 30°C | Neutral | Drug Delivery | Stability |
DPG | Surfactant | 350 g/mol | 25°C | Neutral | Lipid Nanoparticle Formulations | Biocompatibility |
DPPC | Surfactant | 600 g/mol | 50°C | Neutral | Drug Delivery | Stability |
DSPC | Surfactant | 650 g/mol | 55°C | Neutral | Gene Delivery | Compatibility |
DMPC | Surfactant | 700 g/mol | 58°C | Neutral | Lipid Nanoparticle Formulations | Stability |
DOPC | Surfactant | 780 g/mol | 62°C | Neutral | Drug Delivery | Biocompatibility |
DLPC | Surfactant | 590 g/mol | 49°C | Neutral | Drug Delivery | Stability |